Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study

Lancet
Edward F McKoneMoira L Aitken

Abstract

Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of CFTR genotype on mortality and disease phenotype. Using the US Cystic Fibrosis Foundation National Registry, we did a retrospective cohort study to compare standardised mortality rates for the 11 most common genotypes heterozygous for DeltaF508 with those homozygous for DeltaF508. Of the 28455 patients enrolled in the registry at the time of our analysis, 17853 (63%) were genotyped. We also compared the clinical phenotype, including lung function, age at diagnosis, and nutritional measures, of 22 DeltaF508 heterozygous genotypes. Mortality rates and clinical phenotype were also compared between genotypes classified into six classes on the basis of their functional effect on CFTR production. Between 1991 and 1999, genetic and clinical data were available for 17853 patients with cystic fibrosis, which was 63% of the total cohort. There were 1547 deaths during the 9 years of follow-up. In the analysis of the 11 most common genotypes, DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/3849+10kbC-->T, and DeltaF508/2789+5G-->A had a significantly lower mortality rate (4.7,...Continue Reading

References

Nov 1, 1992·Trends in Genetics : TIG·L C Tsui
Apr 30, 1992·The New England Journal of Medicine·E KeremH Levison
Dec 14, 1995·The New England Journal of Medicine·L S Rusakow, M Guarín
Oct 28, 1993·The New England Journal of Medicine·UNKNOWN Cystic Fibrosis Genotype-Phenotype Consortium
Jan 1, 1993·The Journal of Pediatrics·S C FitzSimmons
Dec 1, 1996·Pediatric Pulmonology·E Kerem, B Kerem
Feb 24, 2001·American Journal of Epidemiology·T G LiouB C Marshall
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·M S SchechterS C Fitzsimmons
Aug 3, 2001·Pediatrics in Review·P B Davis
Aug 9, 2001·The European Respiratory Journal·R J MassieC Robertson
Aug 14, 2001·Clinics in Perinatology·L P Shulman, S Elias
Jan 30, 2003·American Journal of Respiratory and Critical Care Medicine·Frank J Accurso, Marci K Sontag

❮ Previous
Next ❯

Citations

Mar 25, 2005·Journal of Genetic Counseling·Elinor Langfelder-SchwindUNKNOWN National Society of Genetic Counselors Subcommittee on Cystic Fibrosis Carrier Testing
Apr 7, 2012·Nature Medicine·Taylor Sitarik Cohen, Alice Prince
Nov 4, 2011·The New England Journal of Medicine·Bonnie W RamseyUNKNOWN VX08-770-102 Study Group
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Fredrick Van GoorPaul Negulescu
Feb 21, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Malgorzata MrugaczAlina Minarowska
Jun 19, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Malgorzata MrugaczJolanta Wysocka
Aug 1, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Malgorzata Mrugacz
Aug 24, 2012·Human Molecular Genetics·P M BarrettE J Topol
Sep 10, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Charles M StromWeimin Sun
Oct 29, 2004·Current Opinion in Pulmonary Medicine·Christopher H Goss, Margaret Rosenfeld
Dec 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Samuel M MoskowitzGarry R Cutting
Sep 27, 2007·Archives of Disease in Childhood·Iolo Doull
Dec 13, 2006·Journal of Medical Genetics·Kitti BuranawutiGarry R Cutting
Aug 30, 2005·Annual Review of Genomics and Human Genetics·Garry R Cutting
Sep 24, 2005·American Journal of Respiratory and Critical Care Medicine·Barry J PlantSeamas C Donnelly
May 13, 2006·American Journal of Respiratory and Critical Care Medicine·Edward F McKoneTerrance J Kavanagh
May 8, 2010·American Journal of Respiratory and Critical Care Medicine·Jerry A NickMarci K Sontag
Mar 9, 2006·American Journal of Respiratory and Critical Care Medicine·Andrew Bush
May 7, 2008·American Journal of Respiratory Cell and Molecular Biology·Uta GriesenbachEric W F W Alton
Aug 4, 2009·American Journal of Respiratory Cell and Molecular Biology·Uta GriesenbachEric W F W Alton
Jun 1, 2013·The European Respiratory Journal·Margaret RosenfeldStephanie D Davis
Jan 25, 2013·Journal of Clinical Bioinformatics·Perry G RidgeKarl V Voelkerding
Feb 24, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Maria Luisa BianchiCarla Colombo
Dec 4, 2009·PloS One·Yudi PawitanPatrik K E Magnusson
Jan 5, 2007·Proceedings of the American Thoracic Society·Michael P Boyle
Sep 17, 2013·Drug Design, Development and Therapy·Ruth O'Reilly, Heather E Elphick
Oct 31, 2013·Hepatitis Monthly·Giuseppe Fabio ParisiSalvatore Leonardi
Dec 18, 2013·The Pediatric Infectious Disease Journal·Judith FillauxJean-François Magnaval
Aug 29, 2013·EMBO Molecular Medicine·Norbert OdolczykAleksander Edelman
Jan 14, 2011·Annual Review of Medicine·Melissa A Ashlock, Eric R Olson
Apr 17, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Lieke UijterschoutFrank Brus
Sep 8, 2009·QJM : Monthly Journal of the Association of Physicians·D M ComerJ S Elborn
Oct 12, 2005·Current Opinion in Pulmonary Medicine·Jerry A Nick, David M Rodman
Feb 10, 2016·Clinics in Chest Medicine·Jerry A Nick, David P Nichols
Mar 19, 2005·Human Mutation·Jérôme ClainPascale Fanen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.